Orthopedic Devices - Kazakhstan

  • Kazakhstan
  • The Orthopedic Devices market market in Kazakhstan is expected to witness significant revenue growth, with projected revenue reaching US$78.12m in 2024.
  • This growth is anticipated to continue at an annual growth rate (CAGR 2024-2029) of 5.75%.
  • By 2029, the market volume is estimated to reach US$103.30m.
  • Comparatively, the United States is projected to generate the highest revenue in the global market, with US$16,020.00m in 2024.
  • Kazakhstan's orthopedic device market is witnessing a surge in demand due to the country's aging population and increasing number of sports injuries.

Key regions: France, Netherlands, Europe, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Orthopedic Devices market in Kazakhstan is experiencing significant growth and development due to various factors.

Customer preferences:
Customers in Kazakhstan are increasingly seeking orthopedic devices that provide advanced technology and innovative features. They are looking for devices that offer improved functionality, durability, and comfort. Additionally, customers are also placing a high emphasis on affordability and value for money. They are looking for products that offer high quality at a reasonable price.

Trends in the market:
One major trend in the Orthopedic Devices market in Kazakhstan is the increasing demand for joint replacement surgeries. As the population ages and the prevalence of chronic diseases such as arthritis and osteoporosis rises, there is a growing need for joint replacement procedures. This has led to an increased demand for orthopedic devices such as hip and knee implants. Another trend in the market is the rising popularity of minimally invasive surgical procedures. These procedures offer several benefits such as smaller incisions, reduced scarring, and faster recovery times. As a result, there is a growing demand for orthopedic devices that are specifically designed for minimally invasive surgeries.

Local special circumstances:
Kazakhstan has a rapidly growing healthcare sector, which is contributing to the development of the Orthopedic Devices market. The government has been investing heavily in healthcare infrastructure and facilities, leading to an increase in the number of hospitals and clinics. This has created a favorable environment for the growth of the Orthopedic Devices market. Furthermore, the country has a high prevalence of musculoskeletal disorders, including osteoarthritis and fractures. This has created a significant demand for orthopedic devices to treat these conditions. The government has also implemented initiatives to improve access to healthcare services, which has further fueled the demand for orthopedic devices.

Underlying macroeconomic factors:
The overall economic growth in Kazakhstan has had a positive impact on the Orthopedic Devices market. As the economy continues to grow, the purchasing power of consumers has increased, allowing them to afford expensive medical treatments and devices. This has led to a higher demand for orthopedic devices in the country. Additionally, the government has implemented healthcare reforms to improve the quality and accessibility of healthcare services. These reforms have encouraged private investment in the healthcare sector, leading to the entry of international players in the Orthopedic Devices market. This has further fueled the growth and development of the market. In conclusion, the Orthopedic Devices market in Kazakhstan is developing rapidly due to customer preferences for advanced technology and affordability, the increasing demand for joint replacement surgeries and minimally invasive procedures, the favorable healthcare infrastructure, the high prevalence of musculoskeletal disorders, and the overall economic growth and healthcare reforms in the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)